Objective： To investigate the changes of cyclin L2（CCNL2） gene mRNA and protein during the differentiation of P19 cells to cardiac myocytes, and to explore the relationship between CCNL2 gene and the differentiatio...Objective： To investigate the changes of cyclin L2（CCNL2） gene mRNA and protein during the differentiation of P19 cells to cardiac myocytes, and to explore the relationship between CCNL2 gene and the differentiation of cardiac myocytes. Methods： P19 cells were cultured with 0.9% DMSO for 18 days. Western blots of cardiac troponin I （cTnI） were used to identify cell differentiation. Total RNA was extracted from P19 cells during the process of differentiation at various time points：pre-differentiation（Day 0）, and Day 1 to Day 18. The expression levels of CCNL2 gene mRNA and protein were evaluated by RT-PCR and Western blot, respectively. Results： After being induced to differentiate by DMSO for 4 days in suspension, spontaneously and rhythmically beating ceils were seen at 8 day, which were cTnI-positive. In P19 cells, both the expression level of CCNL2 gene mRNA and protein were gradually down-regulated. Conclusion： Both the expression of CCNL2 gene and protein were down-regulated during the process of the differentiation of P19 cells into cardiac myocytes, suggesting a possible role for this cyclin in their differentiation.展开更多
细胞毒性T细胞相关抗原(Cytotoxic T Lymphocyte Associated Antigen 4,CTLA-4)是体内重要的免疫负调控因子,它可与CD28竞争跟B7分子的结合,抑制T细胞的活化.程序性死亡蛋白配体2(Programmed Death Ligand-2,PD-L2)可以和其受体程序性...细胞毒性T细胞相关抗原(Cytotoxic T Lymphocyte Associated Antigen 4,CTLA-4)是体内重要的免疫负调控因子,它可与CD28竞争跟B7分子的结合,抑制T细胞的活化.程序性死亡蛋白配体2(Programmed Death Ligand-2,PD-L2)可以和其受体程序性死亡因子1(Programmed Death 1,PD-1)结合,产生的信号可以抑制TCR(T Cell Receptor)介导的T细胞增殖和细胞因子产生.为了得到一种新型的高效免疫负调控蛋白,从人基因组中克隆了CTLA-4和PD-L2胞外区,并在大肠杆菌中实现了其融合表达和纯化.ConA转化实验表明,PD-L2/CTLA-4融合蛋白能显著抑制小鼠淋巴细胞增殖,抑制率达69%.相比于CTLA-4和PD-L2分子单独使用,抑制率分别提高了23%和10%,混合淋巴实验抑制率达71%,提示其具有免疫负调控功能.展开更多
文摘Objective： To investigate the changes of cyclin L2（CCNL2） gene mRNA and protein during the differentiation of P19 cells to cardiac myocytes, and to explore the relationship between CCNL2 gene and the differentiation of cardiac myocytes. Methods： P19 cells were cultured with 0.9% DMSO for 18 days. Western blots of cardiac troponin I （cTnI） were used to identify cell differentiation. Total RNA was extracted from P19 cells during the process of differentiation at various time points：pre-differentiation（Day 0）, and Day 1 to Day 18. The expression levels of CCNL2 gene mRNA and protein were evaluated by RT-PCR and Western blot, respectively. Results： After being induced to differentiate by DMSO for 4 days in suspension, spontaneously and rhythmically beating ceils were seen at 8 day, which were cTnI-positive. In P19 cells, both the expression level of CCNL2 gene mRNA and protein were gradually down-regulated. Conclusion： Both the expression of CCNL2 gene and protein were down-regulated during the process of the differentiation of P19 cells into cardiac myocytes, suggesting a possible role for this cyclin in their differentiation.
文摘细胞毒性T细胞相关抗原(Cytotoxic T Lymphocyte Associated Antigen 4,CTLA-4)是体内重要的免疫负调控因子,它可与CD28竞争跟B7分子的结合,抑制T细胞的活化.程序性死亡蛋白配体2(Programmed Death Ligand-2,PD-L2)可以和其受体程序性死亡因子1(Programmed Death 1,PD-1)结合,产生的信号可以抑制TCR(T Cell Receptor)介导的T细胞增殖和细胞因子产生.为了得到一种新型的高效免疫负调控蛋白,从人基因组中克隆了CTLA-4和PD-L2胞外区,并在大肠杆菌中实现了其融合表达和纯化.ConA转化实验表明,PD-L2/CTLA-4融合蛋白能显著抑制小鼠淋巴细胞增殖,抑制率达69%.相比于CTLA-4和PD-L2分子单独使用,抑制率分别提高了23%和10%,混合淋巴实验抑制率达71%,提示其具有免疫负调控功能.
